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Introduction 
 
Patients with severe aortic stenosis (AS) are 
subjected to long-standing pressure overload of 
left ventricle (LV), leading to LV hypertrophy and 
dysfunction [1]. At the early stage of disease, 
when ejection fraction (EF) is still preserved, 
subclinical systolic abnormalities that may con-
tribute to symptoms can be underestimated by 
conventional echocardiography. However it 
would be clinically helpful to detect early subtle 
effects of aortic valve replacement on LV sys-
tolic function [2, 3]. 
 
Myocardial deformation imaging with determi-
nation of myocardial strain and strain rate de-
rived from tissue Doppler echocardiography has 
been proposed as a reliable mean for the detec-
tion of any clinical and subclinical regional LV 
dysfunction in several diseases [4, 5].  
 
However, this technique presents the disadvan-
tage of being considerably angle dependent [6]. 
The recent development of two-dimensional 
(2D) strain based on speckle tracking of 2D 
grayscale images overcomes this limitation [7-
10]. The application of these indexes to AS and 
its clinical significance have not still been fully 
established [2, 11, 12].  
 
Recent studies have demonstrated that tran-
scatheter aortic valve implantation (TAVI) offers 
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increase in aortic valve area (AVA: 1.08±0.31 cm2/m2; p<0.0001). 2D longitudinal systolic strain showed a signifi-
cant improvement in all patients, both at septal and lateral level, as early as 72 h after procedure (septal: -14.2±5.1 
vs -16.7±3.7%, p<0.001; lateral: -9.4±3.9 vs -13.1±4.5%, p<0.001; respectively) and continued at 3 months follow-
up (septal: -18.1±4.6%, p<0.0001; lateral: -14.8±4.4%, p<0.0001; respectively). Conventional echocardiography  
after TAVI proved a significant reduction of LV end-systolic volume and of LV mass with a mild improvement of LV 
ejection fraction (EF) (51.2±11.8 vs 52.9±6.4%; p<0.02) only after three months. 2D strain seems to be able to de-
tect subtle changes in LV systolic function occurring early and late after TAVI in severe AS, while all conventional echo 
parameters seem to be less effective for this purpose. Further investigations are needed to prove the real prognostic 
impact of these echocardiographic findings. 
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a viable and “less invasive” option for the treat-
ment of critical aortic stenosis patients at high 
risk with conventional surgery [13, 14]. This 
technique, in fact, can decrease LV elevated 
afterload in patients with AS, acutely reducing 
transaortic pressure gradients. However, its 
effects on LV systolic function are currently un-
known. 
 
Our aim is to evaluate whether 2D strain and 
strain rate are sensitive enough to detect subtle 
improvement in regional LV systolic function 
immediately after TAVI. 
 
Materials and methods 
 
Patient population 
 
From September 2007 to December 2010 we 
consecutively selected 50 patients who under-
went successful TAVI with third-generation self-
expanding CoreValve prosthesis (Medtronic, CV 
Luxembourg S.a.r.l.) at the Cardiac Thoracic and 
Vascular Department of the University of Pisa. 
Inclusion criteria for TAVI were the following: 1) 
severe native AS with an area <1 cm2 or <0.6 
cm2/m2 and age 80 years or a logistic Euro-
SCORE of 15% or age 65 years and at least one 
of the following complications: liver cirrhosis, 
pulmonary insufficiency (forced expiratory vol-
ume in one second <1l), previous cardiac sur-
gery, pulmonary hypertension 60 mmHg, porce-
lain aorta, recurrent pulmonary embolus, right 
ventricular insufficiency, thoracic burning se-
quelae with contraindication for open chest sur-
gery, history of mediastinum radiotherapy, se-
vere connective tissue disease with contraindi-
cation for surgery, or cachexia (body mass index 
<18 kg/m2). 2) Echocardiographic aortic valve 
annulus diameter 20 and 27 mm. 3) ascending 
aorta diameter <45 mm at the sinotubular junc-
tion [15, 16]. Patients with a prior pace-maker 
or requiring definitive pacemaker implantation 
after TAVI and those with a myocardial scar 
were excluded from the study.  All patients gave 
written informed consent for the procedure.  
 
Preinterventional morphological patient screen-
ing included transthoracic as well as transe-
sophageal echocardiography, computed tomo-
graphic angiography, and invasive cardiac 
evaluation with coronary angiogram and left 
ventriculography [17, 18]. Patients baseline 
operative risk was estimated by the logistic Eu-
roSCORE and the STS score [19, 20].  
Device description and procedure 
 
The CoreValve aortic valve prosthesis consists 
of a trileaflet bioprosthetic porcine pericardial 
tissue valve, which is mounted and sutured in a 
self-expanding nitinol stent. Further details of 
the device have already been described in previ-
ous studies [14, 16] Vascular access was ob-
tained either by percutaneous approach 
through the common femoral artery with pre-
implantation of a vascular closure device 
(Prostar XL, Abbott Vascular, Abbott Park, IL), or 
by surgical cut down of the subclavian artery 
[21]. The procedure was performed with the 
patient under local anesthesia with a mild sys-
temic sedative treatment, according to patients 
needs [22] [23]. Valvuloplasty with a 22 mm or 
25 mm balloon (NuCLEUS™ PTV, NuMED Inc., 
Hopkinton, NY) under rapid pacing at 180 bpm 
was performed before CoreValve deployment. 
The prosthesis was then deployed retrograde 
over a stiff guide wire placed in the left ventri-
cle, under fluoroscopic guidance. After the 
placement, this kind of valve starts to work im-
mediately. 
 
Two valve size of 26 and 29 mm expanded di-
ameters were available. Aspirin (100 mg daily) 
and clopidogrel (300 mg oral load, followed by 
75 mg daily) were given at least 3 days before 
the procedure; aspirin was continued indefi-
nitely, while clopidogrel was administered for 3 
to 6 months. Acute procedural success was de-
fined as as the adequate technical placement 
of the valve within the aortic root with absence 
of periprocedural major adverse cardiovascular 
and cerebral events in the first 48 h after device 
implantation [13]. 
 
Clinical follow-up and transthoracic echocardi-
ography were performed after 72 h and 3 
months after device implantation.  
 
Pre-and post-operative conventional 2D Color 
Doppler Echocardiography 
 
All echocardiographic measurements were per-
formed using a commercially available ultra-
sound system (Vivid 7, General Electric Health-
care, Milwaukee, WI) equipped with a harmonic 
4.0-MHz  variable-frequency phased-array trans-
ducer. The end-diastolic LV diameter (LVEDD), 
end-systolic LV diameter (LVESD), end-diastolic 
thickness of ventricular septum (EDSth) and 
end-diastolic thickness of LV posterior wall 
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(EDPWth) were measured by M-mode echocardi-
ography. Left ventricular mass (LVM) was calcu-
lated with the corrected formula of the Ameri-
can Society of Echocardiography and was in-
dexed for body surface area (LVMbs) and height 
(LVMh) (h 2.7). 
 
LV mass index was determined by dividing the 
LV mass measure by the body surface area (g/
m2) (LMVbs) and by height (LVMh) (h 2.7). LV end
-diastolic volume (EDV) and end-systolic volume 
(ESV) were calculated by the apical 2- and 4-
chamber views using a modified Simpson’s 
method. LV ejection fraction was calculated as 
ejection fraction (EDV-ESV)/EDV *100. Transmi-
tral flow and LV outflow velocity patterns were 
obtained by the apical long-axis view with the 
pulsed Doppler method.  
 
Transaortic peak velocity was measured by con-
tinuous wave Doppler echocardiography and 
pressure gradient was calculated using the sim-
plified Bernoulli equation. The aortic valve area 
was obtained by the continuity equation method 
and was normalized for the body surface area to 
find the aortic valve area index.  
 
Diastolic function was assessed by measuring 
peak velocities of the E wave (early diastole), 
the A wave (late diastole), the deceleration time 
of the E wave, and the E’ wave (average of early 
diastolic lateral and septal mitral annulus veloc-
ity) [24, 25]. In particular, we considered  the 
ratio (E/E’) between  transmitral early diastolic 
flow velocity (E) and early velocity of mitral an-
nulus motion ( E’) as expression of left ventricu-
lar diastolic pressure [26]. 
 
Pre-and post-operative Two-Dimensional Strain 
Imaging 
 
We acquired LV short-axis view at the mid level 
and LV 4-chamber view using a high frame rate 
(80 frames/sec). The mid short-axis view con-
tained the papillary muscles. At each plane, 3 
consecutive cardiac cycles were acquired at end 
expiration breath holding and stored digitally on 
a hard disk for off line analysis. Image analysis 
was performed off line on a PC workstation us-
ing custom analysis software (Echopac PC, Ver-
sion 6.0.X, GE Healthcare, Fairfield, CT). The LV 
endocardial border of the end-systolic frame 
was manually traced, automatically creating a 
region of interest including the entire transmu-
ral wall for all patients with the software select-
ing natural acoustic markers moving with the 
tissue [27, 28]. 
 
2D LV strain and strain rate were measured 
using a dedicated software package. In the pre-
sent study, longitudinal strain and strain rate 
were assessed at the mid lateral and septal 
walls on the apical 4-chamber view. In fact, the 
mid segments were both little influenced by 
basal and apical torsion and better reflected the 
deformation phenomenon. Circumferential and 
radial strain and strain rate were assessed in 
the 6 LV walls on the parasternal LV short-axis 
view at the chordae tendineae level and their 
average values were used for comparison [29]. 
The intra-class correlation coefficient (ri) was 
calculated according to Bland and Altman’s pro-
cedure[30]. Nearly three values of 2D Strain 
were sampled for each patient and for each 
segment: the correlation coefficient (ri) was 
0.88. 
 
Statistical analysis 
 
Categorical variables were presented as fre-
quencies and were compared by chi-square 
test. Continuous variables were presented as 
mean ± standard deviation. The comparison of 
a single group over different points of time was 
achieved by the analysis of variance for re-
peated measures.. Linear regression analysis 
was made to test the correlation between the 
variations, before and after procedure, of func-
tional and structural ultrasonic parameters. A p 
value <0.05 was considered statistically signifi-
cant. 
 
Results 
 
Patient baseline characteristics 
 
Baseline clinical and echocardiographic data 
are shown in Table 1. Mean age was 82.4±5.9 
years with a mean EuroScore of 19.3%. Accord-
ing the echocardiographic test, all patients had 
severe AS, with AVA averaging between 
0.32±0.20 cm2/m2. Peak aortic pressure gradi-
ent and mean pressure gradient were 86.2 ± 
22.5 mmHg and 53.2 ± 15.2 mmHg respec-
tively. LV ejection fraction averaged between 
51.8±11.8 and it was lower than 45% only in 3 
patients. 
 
Acute procedural and follow-up results 
 
Acute device success was achieved in all pa-
tients (100%). In 2 patients a suboptimal place-
2D strain and transcatheter aortic valve implantation  
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ment of the prosthesis with remaining aortic 
regurgitation had to be corrected by implanta-
tion of a second CoreValve prosthesis 
(prosthesis in prosthesis). Neither aortic dissec-
tion nor procedural coronary flow impairment 
was observed in the entire study population. 
Thirty-one (63%) patients received a 26-mm 
valve and 19 (37%) patients received a 29-mm 
valve. 
 
There were no immediate changes in aortic sys-
tolic and diastolic pressure or in heart rate, 
whereas LV systolic and LV end diastolic pres-
sures significantly decreased after TAVI 
(163.2±26.5 vs 131.3±31.2 mmHg,  p<0.0001 
and 17.1±4.8  vs  12.3±4.3 mmHg,  p<0.0001 
respectively). Overall mortality at 90 days was 
14% (n=7). Five deaths occurred peri proce-
durally: 3 patients died of cardiogenic shock 
(baseline ejection fraction <45%), 1 cardiac 
tamponade and 1 patient died after a major 
stroke. There were 2 non-cardiac deaths occur-
ring after 30 days. Furthermore, at 3 months 
follow-up patients in class NYHA I was 90% and 
in class II were 10%.  
 
Pre-and post-operative conventional 2D Color 
Doppler Echocardiography 
 
Standard echocardiographic parameters before 
and after TAVI are shown in Table 2. Early after 
procedure (72 h), transaortic peak pressure 
gradient assessed by echocardiography was 
significantly reduced (18.6±8.3 mmHg; p 
<0.0001), as mean pressure gradient 
(11.4±5.9 mmHg;p<0.0001) with concomitant 
increase in AVA (1.08±0.31 cm2/m2;p<0.0001). 
LV ejection fraction improved with a mild signifi-
cance only at 3 months follow-up (51.2±11.8 vs 
52.9±6.4%;p<0.02). Obviously LVM, LVMh and 
LVMbs reduced significantly at three months 
follow-up (p<0.0001) (Table 2). No LV diastolic 
function index showed improvement early or/
and late except for E/E’ ratio that significantly 
improved, both at septal and lateral level, only 
after 3 months follow-up (septal: 20.1±8.1 vs 
Table 1. Data of the clinical and echocardiographic variables at baseline 
  (n=50) 
Age, years (mean ± SD) 82.4±5.9 
Logistic EuroScore, % 19.3±11.4 
Female gender,n (%) 27 (54%) 
Body surface area, m2 (mean± SD) 1.77±0.18 
Body mass index, kg/m2 24.2±3.7 
PAS, mmHg (mean± SD) 131.2±15.2 
PAD, mmHg (mean± SD) 71.2±12.1 
Prior coronary artery disease, n(%) 5 (10%) 
Prior cerebral ischemic events, n(%) 5 (10%) 
Peripheral vascular disease, n(%) 10 (20%) 
Severe lung disease, n(%) 6 (12%) 
Diabetes mellitus, n(%) 15 (30%) 
Hypertension, n(%) 28 (56%) 
NYHA class II 20 (40%) 
NYHA class III-IV 30 (60%) 
LVEDD, cm (mean± SD) 5.2 ± 0.5 
LVEDV, ml (mean± SD) 103.1 ± 40.8 
LV ejection fraction, % (mean± SD) 51.2±11.8 
Peak aortic jet velocity, m/sec (mean± SD) 4.5±0.7 
Peak pressure gradient, mmHg (mean± SD) 86.2 ± 22.5 
Mean pressure gradient, mmHg (mean± SD) 53.2 ± 15.2 
Aortic valve area indexed, cm2/m2 (mean± SD) 0.32 ± 0.20 
LVEDD, left ventricular end-diastolic diameter; LVEDV, left ventricular end-diastolic volume; NYHA, New York Heart 
Association. 
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15.3±5.6; p<0.0001 and lateral: 17.8±7.4 vs 
14.2±4.1; p<0.0001, respectively). 
 
Pre-and post-operative Two-Dimensional Strain 
Imaging 
 
The improvement of longitudinal systolic 2D 
strain was significant both at septal and lateral 
level already 72 h after procedure (septal: -
14.2±5.1 vs -16.7±3.7%, p<0.001; lateral: -
9.4±3.9 vs -13.1±4.5%, p<0.001; respectively) 
and continued at 3 months follow-up (septal:-
18.1±4.6%, p<0.0001; lateral:-14.8±4.4%, 
p<0.0001; respectively) (Table 3). 
 
Baseline patients in NYHA classes III to IV had a 
significant lower longitudinal systolic strain at 
septal level compared to patients in NYHA 
classes I to II (-16.8±3.3% vs 11.7±5.1%, 
p<0.0001; respectively) (Figure 1). 
 
Furthermore we found a mild significant correla-
tion between the improvement of NYHA class 
after three months follow-up and the improve-
ment of longitudinal systolic strain at septal 
level (r=0.37; p<0.02). 
Early and late diastolic longitudinal 2D strain 
rate didn’t show significant improvement at 72 
h after procedure and at 3 months follow up. 
Table 2. Echo-Doppler conventional parameters 
  Baseline 
(n=50) 
72 h after pAVI 
(n=45) 
Follow-up 
(n=43) 
p< 
  Mean ± SD Mean ± SD Mean ± SD   
Echo-Doppler Parameters         
LVEDD (cm) 5.21 ± 0.52 5.12 ± 0.48 5.09 ± 0.49 >0.2 
LVESD (cm) 3.31 ± 0.71 3.29 ± 0.62 3.01 ± 0.61° 0.008 
Fractional shortening (%) 36.2 ± 12.1 36.4 ± 9.5 39.8 ± 11.2 >0.2 
LVEDV (ml) 103.1 ± 40.81 107.3 ± 40.1 94.8 ± 26.2 >0.2 
LV ejection fraction (%) 51.2±11.8 52.1 ± 8.1 52.9 ± 6.4* 0.02 
LVM (g) 305.8 ± 47.9 304.4 ± 46.7 279.1 ± 55.4° 0.0001 
LVMh (g/m2.7) 81.4 ± 19.8 81.1 ± 21.0 70.4 ± 19.6° 0.0001 
LVMbs (g/m2) 176.9 ± 30.1 177.7 ± 24.4 163.5 ± 31.4° 0.0001 
Peak aortic jet velocity, m/sec (m/sec) 4.5±0.7 1.9 ± 0.6° 2.2 ± 0.4° 0.0001 
Peak pressure gradient (mmHg) 86.2 ± 22.5 18.6 ± 8.3° 18.9 ± 7.1° 0.0001 
Mean pressure gradient (mmHg) 53.2 ± 15.2 11.4 ± 5.9° 11.8 ± 5.4° 0.0001 
Aortic valve area (cm2/m2) 0.32 ± 0.20 1.08 ± 0.31° 1.12 ± 0.38° 0.0001 
 (E), cm/s 0.71±0.31 0.74±0.36 0.81±0.34 >0.2 
  E/A 0.66±0.24 0.83±0.61 0.92±0.62 >0.2 
PW TDI E/Es 20.1 ± 8.1 21.4 ± 7.8 15.3 ± 5.6° 0.0001 
PW TDI E/El 17.8 ± 7.4 18.1 ± 6.4 14.2 ± 4.1° 0.0001 
LVEDD, left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; LVEDV, left ventricular 
end-diastolic volume; LVESV, left ventricular end-systolic volume; LVM: left ventricular mass; LVMh: left ventricular 
mass indexed for height; LVMbs: left ventricular mass indexed for body-surface; E: early diastolic transmitral veloc-
ity; E/A: ratio between  early diastolic transmitral velocity (E) and late diastolic transmitral velocity ( A); PW E/Es: 
ratio between  early diastolic transmitral flow velocity (E) and early velocity of septal mitral anulus motion ( Es); PW 
E/El: ratio between  early diastolic transmitral flow velocity (E) and early velocity of lateral mitral anulus motion ( El). 
  
 
Figure 1. Baseline longitudinal systolic strain at sep-
tal level of patients in NYHA classes III to IV com-
pared to patients in NYHA classes I to II. 
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Systolic longitudinal 2D strain rate, instead, 
significantly improved  at septal and lateral level 
72 h after procedure (-0.8±0.3 vs -0.9±0.3 sec -
1, p<0.001 and -0.7±0.3 vs -0.9±0.4 sec -1, 
p<0.001; respectively) and 3 months later (-
1.1±0.3 sec -1, p<0.0001 and -0.8±0.3 sec -1, 
p<0.0001; respectively).  
 
Only after 3 months we observed a significant 
improvement of radial and circumferential 
strain at each segment with the concomitant 
regression of LVM (Table 3). No parameter of 
radial and circumferential 2D strain rate 
showed significant changes at 72 h after proce-
dure and at 3 months follow up. 
 
Correlation between strain values and AS pa-
rameters before and after TAVI 
 
We analyzed the relationship between preopera-
tive strain parameters and AS severity parame-
ters in all patients and we found a significant 
correlation between LV longitudinal strain at 
septal and lateral level and AVA (Figure 2). Fur-
thermore, already early after the procedure, we 
detected a significant correlation between the 
improvement of LV longitudinal strain both at 
septal and lateral level (Δ LV longitudinal strain) 
and the increase of aortic valve area (Δ AVA) 
(Figure 3).  
 
Discussion 
  
The main findings of the present study include: 
1. A significant improvement of aortic valve 
function after the procedure as documented by 
the reduction of transprosthetic gradients whit 
the concomitant increase of AVA both early and 
follow-up; 2. A Significant improvement of sys-
tolic longitudinal 2 D strain early and after 3 
months even if LVEF mildly improved only at 
three months follow up;  3. A Significant im-
provement of radial and circumferential 2D 
strain only after 3 months with a concomitant 
reduction of LVM; 4. The significant correlation 
between the improvement of LV longitudinal 
Table 3. Left ventricular longitudinal, radial and circumferential strain values assessed 
by speckle tracking 
  Baseline 
(n=50) 
72 h after pAVI 
(n=45) 
Follow-up 
(n=43) 
P< 
  Mean ± SD Mean ± SD Mean ± SD   
LV Longitudinal 2D 
strain (%) 
        
Segments         
   Mid septal -14.2 ± 5.1 -16.7 ± 3.7° -18.1 ± 4.6° 0.0001 
   Mid lateral -9.4 ± 3.9 -13.1 ± 4.5° -14.8 ± 4.4° 0.0001 
LV Radial 2D strain 
(%) 
        
Segments         
    Anterior 27.9 ± 13.6 29.2 ± 15.1 45.1 ± 16.7° 0.0001 
    Anteroseptal 25.9 ± 12.7 28.9 ± 14.6 41.9 ± 17.9° 0.0001 
    Septal 26.1 ± 13.4 31.3 ± 14.3 45.2 ± 19.5° 0.0001 
    Inferior 25.8 ± 12.6 32.5 ± 16.6 48.1 ± 18.3° 0.0001 
    Posterior 27.4 ± 15.4 32.8 ± 15.9 49.8 ± 16.3° 0.0001 
    Lateral 28.9 ± 14.9 33.1 ± 14.4 50.1 ± 15.8° 0.0001 
LV Circumferential 
2D strain (%) 
        
Segments         
    Anterior -21.5 ± 8.9 -21.8 ± 7.6 -25.8 ± 8.9° 0.007 
    Anteroseptal -16.1 ± 6.8 -15.9 ± 6.1 -19.5 ± 7.4° 0.001 
    Septal -12.1 ± 5.1 -13.9 ± 5.5 -16.7 ± 7.2° 0.001 
    Inferior -11.4 ± 4.7 -13.4 ± 6.2 -15.9 ± 7.1° 0.001 
    Posterior -13.1 ± 7.1 -14.8 ± 7.2 -19.6 ± 6.1° 0.0001 
    Lateral -17.2 ± 8.5 -18.3 ± 6.9 -25.1 ± 8.4° 0.0001 
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strain at septal level and the improvement of 
haemodynamic parameters early after the pro-
cedure. 
 
The excessive pressure overload in AS causes 
an increase of systolic wall stress that deter-
mines a significant left ventricular concentric 
hypertrophy. In the evolution of AS, patients 
frequently develop global LV dysfunction evi-
denced by low EF. However, at the early stage of 
disease, when EF is still preserved, subclinical 
myocardial dysfunction can be detected in the 
form of myocytes hypertrophy and reactive inter-
stitial fibrosis [31, 32]. In fact we found a signifi-
cant correlation between baseline LV longitudi-
nal strain at septal and lateral level and AVA 
Figure 2. Baseline Correlation between LV longitudinal strain at septal and lateral level and aortic valve area. 
Figure 3. Correlation between the early improvement of LV longitudinal strain (baseline-72 h) both at septal and lat-
eral level (Δ LV longitudinal strain) and the increase of aortic valve area (baseline-72 h) (Δ AVA). 
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(Figure 2). 
 
Conventional echocardiography is an appropri-
ate instrument to detect global LV dysfunction 
while tissue Doppler imaging, in particular strain 
and strain rate imaging, can better detect subtle 
systolic myocardial function damage before 
global LV dysfunction occurrence [2, 33].  
 
Although aortic valve replacement has a favor-
able impact on LV remodeling with an immedi-
ate afterload decrease, in the present study 
LVEF showed a mild improvement only after 
three months follow (p<0.02). That might be 
correlated to the preserved baseline LV EF 
(51.2% ± 11.8). Doppler and strain imaging are 
preferred for the analysis of early subtle 
changes in systolic function after aortic valve 
replacement when EF is preserved [2, 3]. In 
fact, in our study longitudinal systolic strain 
shows an early significant improvement 
(confirmed even after 3 months follow up) after 
TAVI both at septum and lateral wall level even 
when the EF has not improved. Furthermore the 
early variation of longitudinal strain was signifi-
cantly related to the increase of AVA (Figure 3). 
 
Radial and circumferential systolic strain dem-
onstrates a late significant improvement both 
with ESV and LVM reduction and EF improve-
ment.  
 
Our findings confirm that the hemodynamic im-
provement determined by TAVI induces early LV 
systolic functional improvement detected only 
by longitudinal 2D strain and late structural sig-
nificant modification such as LV hypertrophy 
regression and LVEF improvement detected 
also by conventional echocardiography [3, 34, 
35].  
 
The actual possibility to analyze by 2D strain 
ventricular function in all three deformation 
components [36] (longitudinal, radial and 
circumferential) allows to discover the complex 
physiopathology modification induced by TAVI, 
with an acute afterload reduction [3]. 
 
Only after three months, we observed a signifi-
cant improvement of radial and circumferential 
strain, in parallel to a significant decrease of E/
E’ ratio, indirect expression of left ventricular 
end diastolic pressure. The chronic reduction of 
afterload determined by TAVI could further in-
duce a significant reduction of LV mass, ex-
pressing the LV inverse remodeling [34].  
In the present study, therefore, the early LV lon-
gitudinal strain improvement could represent a 
response to an acute reduction of afterload de-
riving from TAVI procedure; the late improve-
ment both of radial and circumferential strain, 
instead, could be caused by the significant re-
duction of  left ventricular hypertrophy and the 
concomitant decrease of collagen content.  
 
The clinical relevance of our findings is that lon-
gitudinal 2D strain pre e post procedure allows 
selecting patients who manifest an improve-
ment of myocardial deformability post proce-
dure and those who do not show any improve-
ment that, consequently, will surely need a fur-
ther attention and therapeutic support. 
 
Study limitations  
 
The low number of patients and the short follow-
up represent a limitation for the study together 
with the new methodology used. Furthermore 
since the analysis has been done on AS patients 
with normal EF or mildly reduced EF, it is even 
more difficult to assess early improvements of 
LV function based on the variation of  conven-
tional echocardiographic parameters. 
 
The present data have been obtained by the 
implantation of one specific type of valve pros-
thesis (Corevalve). Even if we do not expect any 
difference, these data would need to be repli-
cated with other types of valve prosthesis, such 
as Edwards-SAPIEN valve. Further studies are 
needed to confirm the results.   
 
Conclusions 
 
The 2D strain technology can early detect the 
subtle improvement of global and regional LV 
systolic function immediately after TAVI while all 
conventional echo parameters prove to be less 
effective for this purpose. Only after three 
months follow up, it is possible to observe a 
significant LVM reduction and a mild EF im-
provement. 
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